RA CAPITAL MANAGEMENT, L.P. Diversified Active

Location: Boston, MA

CIK: 0001346824 · Show all filings

Period: Q1 2017 (← Previous) (Next →)

Filing Date: May 15, 2017

Total Value: $815M (100.0% shares, 0.0% debt)

Holdings (24)

WVE WAVE LIFE SCIENCES LTD 23.9%
Value $195M Shares 7,088,651 Est. Cost $15.68 Unrealized +78.1%
ASND ASCENDIS PHARMA A S 18.6%
Value $151M Shares 5,409,990 Est. Cost $17.65 Unrealized
AVEXIS INC 15.2%
Value $124M Shares 1,625,211 Est. Cost $31.86 Unrealized
ACHILLION PHARMACEUTICALS INC 7.0%
Value $57.4M Shares 13,633,220 Est. Cost $6.18 Unrealized
AQUINOX PHARMACEUTICALS INC 4.4%
Value $36.19M Shares 2,184,047 Est. Cost $13.67 Unrealized
BCRX BIOCRYST PHARMACEUTICALS 3.6%
Value $29.31M Shares 3,489,795 Est. Cost $9.20 Unrealized -24.4%
RA PHARMACEUTICALS INC 3.5%
Value $28.78M Shares 1,351,808 Est. Cost $15.19 Unrealized
MYOVANT SCIENCES LTD 3.4%
Value $27.57M Shares 2,348,422 Est. Cost $12.19 Unrealized
ZOGENIX INC 3.3%
Value $26.6M Shares 2,451,237 Est. Cost $13.32 Unrealized
ESPR ESPERION THERAPEUTICS INC 3.1%
Value $24.88M Shares 704,701 Est. Cost $22.90 Unrealized 0.0%
LOXO ONCOLOGY INC 1.5%
Value $12.58M Shares 298,935 Est. Cost $42.08 Unrealized
ARDX ARDELYX INC 1.3%
Value $10.48M Shares 828,283 Est. Cost $10.51 Unrealized +25.2%
ACORDA THERAPEUTICS INC 1.3%
Value $10.29M Shares 489,828 Est. Cost $21.00 Unrealized
AUDENTES THERAPEUTICS INC 1.1%
Value $9.073M Shares 532,426 Est. Cost $17.81 Unrealized
FOAMIX PHARMACEUTICALS LTD 1.1%
Value $9.01M Shares 1,820,138 Est. Cost $9.26 Unrealized
IGNYTA INC 1.1%
Value $8.818M Shares 1,025,291 Est. Cost $8.60 Unrealized
ONC BEIGENE LTD 1.1%
Value $8.786M Shares 240,000 Est. Cost $29.62 Unrealized
CALITHERA BIOSCIENCES INC 1.0%
Value $8.374M Shares 725,000 Est. Cost $11.55 Unrealized
DICERNA PHARMACEUTICALS INC 1.0%
Value $8.257M Shares 2,428,571 Est. Cost $28.25 Unrealized
TGTX TG THERAPEUTICS INC 1.0%
Value $8.155M Shares 700,000 Est. Cost $10.06 Unrealized -28.6%
PTGX PROTAGONIST THERAPEUTICS INC 1.0%
Value $8.15M Shares 636,248 Est. Cost $13.67 Unrealized +17.9%
KALV KALVISTA PHARMACEUTICALS INC 0.6%
Value $4.616M Shares 591,070 Est. Cost $7.37 Unrealized +1.9%
EIGER BIOPHARMACEUTICALS INC 0.5%
Value $4.056M Shares 354,200 Est. Cost $16.17 Unrealized
MEDICINES CO 0.5%
Value $3.907M Shares 79,899 Est. Cost $33.94 Unrealized